Department of Intensive Care, Ziekenhuisnetwerk Antwerpen (ZNA) Stuivenberg, Lange Beeldekensstraat 267, Antwerp, B-2060, Belgium.
Ann Intensive Care. 2012 Dec 20;2 Suppl 1(Suppl 1):S20. doi: 10.1186/2110-5820-2-S1-S20.
Little is known about the effects of renal replacement therapy (RRT) with fluid removal on intra-abdominal pressure (IAP). The global end-diastolic volume index (GEDVI) and extravascular lung water index (EVLWI) can easily be measured bedside by transpulmonary thermodilution (TPTD). The aim of this study is to evaluate the changes in IAP, GEDVI and EVLWI in critically ill patients receiving slow extended daily dialysis (SLEDD) or continuous venovenous haemofiltration (CVVH) with the intention of net fluid removal.
We performed a retrospective cohort study in ICU patients who were treated with SLEDD or CVVH and in whom IAP was also measured, and RRT sessions were excluded when the dose of vasoactive medication needed to be changed between the pre- and post-dialysis TPTD measurements and when net fluid loss did not exceed 500 ml. The TPTD measurements were performed within 2 h before and after SLEDD; in case of CVVH, before and after an interval of 12 h.
We studied 25 consecutive dialysis sessions in nine patients with acute renal failure and cardiogenic or non-cardiogenic pulmonary oedema. The GEDVI and EVLWI values before dialysis were 877 ml/m² and 14 ml/kg, respectively. Average net ultrafiltration per session was 3.6 l, with a net fluid loss 1.9 l. The GEDVI decreased significantly during dialysis, but not more than 47.8 ml/m² (p = 0.008), as also did the EVLWI with 1 ml/kg (p = 0.03). The IAP decreased significantly from 12 to 10.5 mmHg (p < 0.0001).
Net fluid removal by SLEDD or CVVH in the range observed in this study decreased IAP, GEDVI and EVLWI in critically ill patients although EVLWI reduction was modest.
关于肾脏替代疗法(RRT)通过液体清除对腹腔内压(IAP)的影响知之甚少。通过经肺温度稀释(TPTD)可以轻松地在床边测量全心舒张末期容积指数(GEDVI)和血管外肺水指数(EVLWI)。本研究的目的是评估接受缓慢扩展每日透析(SLEDD)或持续静脉-静脉血液滤过(CVVH)的危重症患者的 IAP、GEDVI 和 EVLWI 的变化,其目的是实现净液体清除。
我们对接受 SLEDD 或 CVVH 治疗且 IAP 也被测量的 ICU 患者进行了回顾性队列研究,并排除了在透析前后的 TPTD 测量之间需要改变血管活性药物剂量以及净液体损失不超过 500ml 的情况下进行的 RRT 治疗。TPTD 测量在 SLEDD 治疗前和治疗后 2 小时内进行;对于 CVVH,在 12 小时间隔前后进行。
我们研究了 9 例急性肾衰竭伴心源性或非心源性肺水肿患者的 25 例连续透析治疗。透析前的 GEDVI 和 EVLWI 值分别为 877ml/m²和 14ml/kg。每次透析的平均净超滤量为 3.6L,净液体损失 1.9L。GEDVI 在透析过程中显著下降,但不超过 47.8ml/m²(p=0.008),EVLWI 也下降了 1ml/kg(p=0.03)。IAP 从 12mmHg 显著下降至 10.5mmHg(p<0.0001)。
在本研究观察到的范围内,SLEDD 或 CVVH 的净液体清除降低了危重症患者的 IAP、GEDVI 和 EVLWI,尽管 EVLWI 的降低幅度较小。